Asensus Surgical, Inc. (ASXC)

Asensus Surgical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8.48	18.74	7.47	19.28	17.53	10.57
Short-Term Investments	0.99	3.97	64.2	80.26	0	0
Cash & Cash Equivalents	9.47	22.71	71.67	99.55	17.53	10.57
Cash Growth	-83.55%	-68.31%	-28.01%	467.89%	65.88%	-85.61%
Receivables	0.68	3.51	2.26	0.75	1.12	0.62
Inventory	9.91	11.22	13.75	15.71	18.85	18.25
Other Current Assets	-0.81	-1.05	-0.8	-2.71	-3.48	-1.48
Total Current Assets	19.25	36.39	86.87	113.3	34.01	27.96
Property, Plant & Equipment	13.56	14.12	14.49	16.32	11.51	4.71
Long-Term Investments	0	0	3.87	37.44	0	0
Goodwill and Intangibles	1.11	1.24	1.58	9.89	22.27	28.6
Other Long-Term Assets	6.9	7.34	9.25	9.53	10.47	13.52
Total Long-Term Assets	21.57	22.7	29.18	73.18	44.25	46.82
Total Assets	40.81	59.09	116.05	186.47	78.26	74.78
Accounts Payable	4.04	4.15	3.35	3.45	1.97	3.58
Deferred Revenue	0.77	0.71	0.47	0.54	0.79	0.85
Current Debt	1.06	1.04	0.8	0.68	1.91	0
Other Current Liabilities	13.43	6.74	5.8	5.18	5.62	8.6
Total Current Liabilities	19.29	12.63	10.41	9.85	10.28	13.02
Long-Term Debt	4.4	4.65	4.74	5.01	2.22	0
Other Long-Term Liabilities	4.1	8.4	1.26	2.37	4.19	6.22
Total Long-Term Liabilities	8.5	13.04	5.99	7.38	6.41	6.22
Total Liabilities	27.79	25.67	16.41	17.23	16.69	19.24
Total Debt	5.46	5.68	5.54	5.69	4.13	0
Debt Growth	2.11%	2.60%	-2.65%	37.78%	-	-
Retained Earnings	-961.87	-939.37	-860.94	-785.37	-722.91	-663.6
Comprehensive Income	-1.1	-0.61	-2.39	-0.26	2.97	-1.37
Shareholders' Equity	13.02	33.41	99.65	169.25	61.57	55.54
Net Cash / Debt	4.02	17.03	66.13	93.86	13.4	10.57
Net Cash / Debt Growth	-92.31%	-74.25%	-29.54%	600.42%	26.81%	-76.26%
Net Cash Per Share	0.01	0.07	0.28	0.41	0.19	0.60
Working Capital	-0.04	23.76	76.46	103.45	23.73	14.93
Book Value Per Share	0.05	0.13	0.42	0.75	0.87	3.13

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).